文献速递肾移植肾小球疾病血液净化与透析

肾移植可改善狼疮肾炎终末期肾病患者的生存

Kidney Transplantation Improves Survival in Lupus Nephritis With End-Stage Kidney Disease.
PubMed 文献 · Kidney Int Rep · 2025-02-03

本研究基于法国REIN登记系统2002至2022年等待肾移植的882例狼疮肾炎终末期肾病患者,将肾移植作为时间依赖变量进行回顾性分析。中位随访80个月,肾移植较继续透析与死亡风险降低60%相关(HR 0.40,95%CI 0.240-0.67,P<0.001),10年患者生存率移植组83%对非移植组60%(P<0.001)。

要点

  • 狼疮肾炎终末期肾病患者肾移植较透析显著降低死亡风险
  • 10年生存率移植组83%显著高于非移植组60%
  • 应早期评估移植资格并及时转诊移植中心

核心结论

  • 与继续透析相比,肾移植与狼疮肾炎终末期肾病患者生存改善相关。

研究设计与样本

  • 回顾性分析法国REIN登记系统2002至2022年等待肾移植的882例狼疮肾炎终末期肾病患者。
  • 肾移植作为时间依赖变量处理以避免不朽时间偏倚。
  • 主要结局为全因死亡,采用Kaplan-Meier分析和校正Cox比例风险模型评估。

主要发现

  • 882例患者中636例(72%)进入等待名单,470例(74%)接受移植。
  • 中位随访80个月,肾移植较继续透析与死亡风险降低60%相关(HR 0.40,95%CI 0.240-0.67,P<0.001)。
  • 10年患者生存率移植组83%,非移植组60%(P<0.001)。
  • 排除活体供肾受者和从等待名单失活患者后敏感性分析支持上述发现。
  • 终末期肾病起病后2年,38%的等待名单患者接受移植;移植后10年移植失败概率为23%。

临床怎么用

  • 对狼疮肾炎终末期肾病患者应早期评估移植资格并及时转诊移植中心以优化结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) and is associated with high morbidity and mortality rates. Although kidney transplantation (KT) is considered the optimal treatment for end-stage kidney disease (ESKD), its survival benefit, specifically in patients with LN-induced ESKD (LN-ESKD), is not well-established. This study aimed to determine the effects of KT on the survival of a national cohort of patients with LN-ESKD. METHODS: We retrospectively analyzed patients with LN-ESKD registered in the French Renal Epidemiology and Information Network (REIN) registry, who were waitlisted for KT between 2002 and 2022. KT was treated as a time-dependent variable to avoid an immortal time bias. The primary outcome was all-cause mortality, which was assessed using Kaplan-Meier analysis and adjusted Cox proportional hazards models. RESULTS: Of the 882 patients with LN-ESKD, 636 (72%) were waitlisted for KT, and 470 (74%) received a transplant. After a median follow-up of 80 months, KT was associated with a 60% reduction in the risk of death compared with remaining on dialysis (hazard ratio [HR]: 0.40, 95% confidence interval [CI]: 0.240-0.67, P < 0.001), with consistent benefits across subgroups. Patient survival at 10 years was 83% for transplant recipients and 60% for nontransplant recipients (P < 0.001). Sensitivity analyses, after excluding recipients of living donors and patients who were inactivated from the waitlist, supported these findings. Two years after the onset of ESKD, 38% of the waitlisted patients under went transplantation. The probability of graft failure was 23% at 10 years posttransplant. CONCLUSION: Compared with patients who remain on dialysis, KT is associated with improved survival in patients with LN-ESKD. Early evaluation of transplant eligibility and timely referral to transplant centers are crucial for optimizing outcomes.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Brilland B, Augusto JF, Michel PA, et al. Kidney Transplantation Improves Survival in Lupus Nephritis With End-Stage Kidney Disease. Kidney Int Rep. 2025. PMID: 40303207. doi:10.1016/j.ekir.2025.01.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。